7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H -pyrrol-1-yl]-5-hydroxy-3-oxoheptanoic acid (887196-30-7)
Identification |
Properties |
Safety Data |
|
|
Other Product
- (2E,5S)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-5-hydroxyhept-2-enoic acid
- 3S,5R isoMer, or (3S,5R)-7-[3-(phenylcarbaMoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calciuM salt
- tert-butyl 2-((7R,9R)-9-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-6,10-dioxaspiro[4.5]decan-7-yl)acetate
- tert-butyl 2-((2R,4R)-4-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-1,5-dioxaspiro[5.5]undecan-2-yl)acetate
- 2-((4R,6R)-6-(2-(3-(phenylcarbamoyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetic acid isopropyl ester
- tert-Butyl (4R,6R)-2-[[[6-(2-4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxan-4-yl]acetate
- Atorvastatin Related Compound C (20 mg) (Difluoro impurity,
or (3R,5R)-7-[3-(phenylcarbamoyl)-4,5-bis(4-fluorophenyl)-
2-isopropyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid
calcium salt)
- (6-2-[2-(4-Fluoro-phenyl)-4-(4-hydroxy-phenylcarbamoyl)-5-isopropyl-3-phenyl-D5-pyrrol-1-yl]-ethyl-2,2-dimethyl-[1,3]-dioxane-4-yl)-acetic Acid, tert-Butyl Ester
- (6-2-[2-(4-Fluoro-phenyl)-4-(2-hydroxy-phenylcarbamoyl)-5-isopropyl-3-phenyl-D5-pyrrol-1-yl]-ethyl-2,2-dimethyl-[1,3]-dioxane-4-yl)-acetic Acid, tert-Butyl Ester
- (6-{2-[2-(4-Fluoro-phenyl)-4-(2-hydroxy-phenylcarbamoyl)-5-isopropyl-3-phenyl-pyrrol-1-yl]-ethyl}-2,2-dimethyl-[1,3]-dioxane-4-yl)-acetic Acid, tert-Butyl Ester
- (6-2-[3-(4-Phenylcarbamoyl-5-(4-fluoro-phenyl)-2-isopropyl-4-phenyl-D5-pyrrol-1-yl]-ethyl-2,2-dimethyl-[1,3]-dioxane-4-yl)-acetic Acid, tert-Butyl Ester
- (3R,5R)-isopropyl 7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoate
- magnesium,(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate,trihydrate
- ((4R,6R)-6-(2-[2-(4-fluoro-phenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrole-1-yl]-ethyl)-2-phenethyl-[1,3,2]dioxaborinane-4-yl)-acetic acid t-butyl ester
- 1-(2-BENZYL-5-ISOPROPYL-4-PHENYL-1H-PYRROL-3-YL)-2-METHYL-PROPAN-1-ONE
- Atorvastatin Related Compound A (20 mg) (Desfluoro impurity,
or (3R,5R)-7-[3-(phenylcarbamoyl)-2-isopropyl-4,5-
diphenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid
calcium salt)
- calcium,(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate,propane-1,2-diol
- Indolizine,7-[5-(4-fluorophenyl)-4-(4-pyridinyl)-1H-pyrrol-3-yl]-3,5,6,8a-tetrahydro-2-phenyl-
- 6-Heptenoic acid,7-[1-(ethylsulfonyl)-4-(4-fluorophenyl)-5-methyl-2-(1-methylethyl)-1H-pyrrol-3-yl]-5-hydroxy-3-oxo-, methyl ester, (E)-
- 6-Heptenoic acid,7-[4-(4-fluorophenyl)-2-(1-methylethyl)-1-(2-thienylsulfonyl)-1H-pyrrol-3-yl]-5-hydroxy-3-oxo-, ethyl ester, (E)-